NIR SHMUEL enters GALMED PHARMACEUTICALS LTD. with 36.49K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001493152-26-010849
36.49K
Baseline shares
100% direct
36.49K
Direct ownership
4 positions
277.00
Derivative underlying
2 instruments
4
Security positions
All direct
Non-Derivative Holdings4
Restricted Share Units
DirectShares owned1.04K
Restricted Share Units
DirectShares owned11.67K
Ordinary Shares
DirectShares owned11.29K
Restricted Share Units
DirectShares owned12.50K
Total
36.49K direct36.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 1.04K | Direct |
| Restricted Share Units | 11.67K | Direct |
| Ordinary Shares | 11.29K | Direct |
| Restricted Share Units | 12.50K | Direct |
| Total | 36.49K | 36.49K direct |
Derivative Holdings2
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
166.00
Shares owned
N/A
Exercise price
2080.8
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
111.00
Shares owned
N/A
Exercise price
558.0
Expiration
—
Exercise window
—
Total
Underlying
277.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 2080.8 | — | — | 166.00 | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 558.0 | — | — | 111.00 | N/A |
| Total | 277.00 | 0.00 | ||||